|
By Annika Tiedemann,
Tuesday, March 2, 2021 3:00 AM
 In a
regular situation, underwriting follows evidence-based principles. But
what about assessing rare or new diseases for which only a little
evidence exists? Handling such diseases in underwriting will be
discussed in the following article.
Read more »
   
|
No comments:
Post a Comment